Article Details

Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress

Retrieved on: 2021-08-09 20:03:45

Tags for this article:

Click the tags to see associated articles and topics

Atara Biotherapeutics Announces Second Quarter 2021 Financial Results and Operational Progress. View article details on hiswai:

Excerpt

Research and development expenses include $8.3 million of non-cash ... deliver off-the-shelf treatments to patients with high unmet medical need.

Article found on: www.cadillacnews.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up